Navigation Links
Noninvasive test for trisomy 21 closer at hand
Date:2/10/2011

St. Louis, MO, February 10, 2011 In 1980 in the United States, approximately 4.5% of all pregnant women were of advanced maternal age. By 2007 that figure had increased to 14%. Women over 35 are at increased risk of giving birth to babies with trisomy 21. In a study published online today in the American Journal of Obstetrics & Gynecology (AJOG), researchers from the Sequenom Center for Molecular Medicine confirmed that DNA sequencing of maternal blood plasma could accurately detect trisomy 21.

"In this study we have taken the next step in evaluating the practical use of fetal DNA sequencing and have shown that it has the potential to be highly accurate in a clinical setting," commented senior author Dirk van den Boom, DPhil. "We have implemented technical improvements that will increase sample throughput and reduce costs. Following completion of an ongoing clinical validation study the above improvements will greatly facilitate introduction into clinical practice. "

Because the plasma of pregnant women contains circulating cell-free (ccf) fetal (ccff) DNA the DNA sequencing method is able to identify the extra chromosome 21 material present in a fetus with trisomy 21. Independent of gestational age assessments, this novel approach allows for direct fetal assessment using massively parallel shotgun sequencing to detect missing or extra chromosomes, rather than surrogate biochemical markers that are used today in clinical practice.

Using samples from 449 high-risk pregnant women, the DNA sequencing method correctly identified 39 trisomy 21 samples and 409 normal samples, and misclassified 1 normal sample as trisomy 21. The overall classification showed 100% sensitivity and 99.7% specificity.

The data show that, in the future, a noninvasive prenatal trisomy 21 test from ccff DNA might be used in concert with other clinical assessments, such as ultrasound, and become an option to better identify those women who would, or would not, benefit from confirmatory invasive diagnostic tests.

According to prenatal testing expert, Lee P. Shulman MD, The Feinberg School of Medicine of Northwestern University, Chicago, "The results of this study point more to a continuation in the improvement in the various non-invasive aneuploidy detection technologies that have been studied for the past two decades; hence, the results of this study can be considered a small step...Many more steps and studies will be needed in order to arrive at the goal that most of us who provide and study prenatal screening and diagnosis have long sought after: a facile, economical, and more accurate approach to prenatal screening and, eventually, an effective noninvasive alternative to invasive prenatal testing. We may not be there yet, but it seems that we have come a bit closer to our ultimate objective."

"This important study, along with another article recently published, suggests that progress is being made towards the realization of prenatal diagnosis of fetal disorders based upon maternal blood analysis and the use of high throughput technologies. While this study shows feasibility for the detection of trisomy 21, further studies are required to establish utility in clinical practice. A new frontier is the diagnosis, not only of trisomy 21 and other genetic disorders of the human fetus, but also the assessment of the functional state of the unborn baby by analysis of circulating fetal and/or placental RNA in the maternal circulation," said Roberto Romero, Chief of the Perinatology Research Branch of NICHD, NIH and Professor of Molecular Obstetrics and Genetics at Wayne State University. Dr. Romero is an Associate Editor of the American Journal of Obstetrics & Gynecology.


'/>"/>

Contact: Nancy Burns
ajogmedia@elsevier.com
314-447-8013
Elsevier Health Sciences
Source:Eurekalert

Related medicine news :

1. New research shows innovative respiratory stress test can quickly detect significant coronary artery disease in a noninvasive setting
2. Noninvasive combination technique may reduce number of breast biopsies
3. Prediction tool helps estimate local recurrence in patients with noninvasive breast cancer
4. Noninvasive Test for Colon Cancer Shows Promise in Early Trial
5. Noninvasive brain stimulation helps improve motor function in stroke patients
6. Noninvasive Glaucoma Test Might Speed Up Detection
7. Idaho House Moves State Closer to Health Care Disaster
8. Heart Stem Cells Move Closer to Human Treatments
9. Stevens Hospital One Step Closer to Affiliation with Swedish
10. Mind Reading Moves Closer to Reality
11. Urine test for kidney cancer a step closer to development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... May 28, 2016 , ... In a part of the city where’s it’s easy to ... farm-to-table Kelowna restaurants is hoping to attract diners with a taste for real food. ... officially opened the doors to Cornerstone Grill, an urban casual restaurant focusing on dishes made ...
(Date:5/27/2016)... ... 27, 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield ... (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their fields and ... of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and ...
(Date:5/27/2016)... ... , ... With over 60 percent of acute stroke survivors being left unable ... aid in the rehabilitation process has steadily increased. Ekso Bionics had been working to ... to stroke. , Ekso Bionics has now received clearance from the U.S. Food and ...
(Date:5/27/2016)... ... May 27, 2016 , ... In ... the many who are unaware of the plight of aphasia. In collaboration with ... the “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively ...
(Date:5/27/2016)... ... 2016 , ... Aimed at nurses and employees in the health care world, ... in the nursing and health care industry. It also provides insight to the developing ... , As the nursing industry is coming out of one of the biggest ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
(Date:5/24/2016)... CHRISTCHURCH, New Zealand , May 24, 2016 ... scanning and informatics solutions for the healthcare sector, has been ... the New Zealand Hi-Tech Awards 2016. Dr ... a fantastic acknowledgement for our team.  It,s really good to ... the burden healthcare internationally. Our products are used in 35 ...
(Date:5/24/2016)... INDIANAPOLIS , May 24, 2016  Joe Marziani has joined VMS BioMarketing as ... chief executive officer, today. In his new role, Marziani will lead the company,s business ... care professionals to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
Breaking Medicine Technology: